Diabetes in the elderly population

Advances in Renal Replacement Therapy

Volumn 7, Issue 1, 2000, Pages 32-51

  Khan, M A ^a   Collins, A J ^a   Keane, W F ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Diabetes mellitus; ESRD; Insulin resistance; Renal disease

Indexed keywords

GLUCOSE; INSULIN;

AGED; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIABETOGENESIS; ELDERLY CARE; ENVIRONMENTAL FACTOR; GLUCOSE METABOLISM; HEREDITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; KIDNEY DISEASE; KIDNEY FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYNDROME X;

EID: 0033985222     PISSN: 10734449     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1073-4449(00)70004-5     Document Type: Article

References (86)

1. Ismail N Becker B Strzelczyk P Renal disease and hypertension in non-insulin-dependent diabetes mellitus Kidney Int 55 1999 1 28
2. 2.U.S. Renal Data System: USRDS 1998 Annual Data Report. National Institutes of Health, National Insti-tute of Diabetes and Digestive and Kidney Diseases. Bet
3. Bennett PH Epidemiology of non-insulin-dependent diabetes LeRoith D Taylor SI Olefsky JM Diabetes Mellitus 1996 Lippincott-Raven New York, NY 455 459
4. Pugh JA Katz MS Geriatrics and diabetes mellitus DeFronzo RA Current Therapy of Diabetes Mellitus 1998 Mosby-Year Book Philadelphia, PA 255 261
5. Reaven GM Banting lecture 1988. Role of insulin resistance in human disease Diabetes 37 1988 1595 1607
6. Olefsky JM Pathogenesis of non-insulin-dependent diabetes (Type II) DeGroot LJ Besser GM Cahill JC Endocrinology 1989 WB Saunders St. Louis, MO 1369 1388
7. Kolterman OG Gray RS Griffin J Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus J Clin Invest 68 1981 957 969
8. Bogardus C Lillioja S Howard BV Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and non-insulin-dependent diabetic subjects J Clin Invest 74 1984 1238 1246
9. DeFronzo RA Tobin JD Andres R Glucose clamp technique: A method for quantifying insulin secretion and resistance Am J Physiol 237 1979 E214 E223
10. Reaven GM Olefsky JM Relationship between hetero-geneity of insulin responses and insulin resistance in normal subjects and patients with chemical diabetes Diabetologia 13 1977 201 206
11. Jackson RA Mechanisms of age-related glucose intolerance Diabetes Care 13 1990 9 19
12. Despres JP Lamarche B Mauriege P Hyperinsu-linemia as an independent risk factor for ischemic heart disease N Engl J Med 334 1996 952 957
13. Haffner SM Miettinen H Insulin resistance implica-tions for type II diabetes mellitus and coronary heart disease Am J Med 103 1997 152 162
14. Reaven GM Insulin resistance and its consequences: Non-insulin-dependent diabetes mellitus and coro-nary heart disease LeRoith D Taylor SI Olefsky JM Diabetes Mellitus 1996 Lippincott-Raven Philadelphia, PA 509 519
15. Reaven GM Lithell H Landsberg L Hypertension and associated metabolic abnormalities-The role of insulin resistance and the sympathoadrenal system N Engl J Med 334 1996 374 381
16. Howard B Pathogenesis of diabetic dyslipidemia Diabetes Rev 3 1995 423 432
17. Pyorala K Pedersen TR Kjekshus J Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Diabetes Care 20 1997 614 620
18. Plehn JF Davis BR Sacks FM Reduction of stroke incidence after myocardial infarction with pravastatin: The Cholesterol and Recurrent Events (CARE) study. The Care Investigators Circulation 19 1999 216 223
19. St Peter JV Khan MA Obesity DePiro JT Talbert RL Yee GC Pharmacotherapy A Pathophysiologic Approach 1999 Appleton & Lange Philadelphia, PA 2334 2354
20. Barker DJP Fetal origins of coronary heart disease BMJ 311 1995 171 174
21. Neel JV Diabetes mellitus: A “thrifty” genotype ren-dered detrimental by “progress” Am J Hum Genet 14 1962 353 362
22. Lev-Ran A Thrifty genotype: How applicable is it to obesity and type 2 diabetes Diabetes Rev 7 1999 1 22
23. Anderson JL Khan MA Davis WS Confirmation of linkage of hereditary partial lipodystrophy to chromosome 1821-22 Am J Med Genet 82 1999 161 165
24. Knowler WC Williams RC Pettitt DJ Gm 3;5,13,14 and Type 2 diabetes mellitus: An association in American Indians with genetic admixture Am J Hum Genet 43 1988 520 526
25. Hill JO Peters JC Environmental contributions to the obesity epidemic Science 280 1998 1371 1374
26. Barker DJP Hales CN Fall CHD Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): Relation to reduced fetal growth Diabetologia 36 1993 62 67
27. McCance DR Pettitt DJ Hanson RL Birth weight and non-insulin dependent diabetes: Thrifty genotype, thrifty phenotype, or surviving small baby genotype? BMJ 308 1994 942 945
28. Ohkubo Y Kishikawa H Araki E Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: Diabetes Res Clin Pract 28 1995 103 117
29. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes Lancet 352 1998 837 853
30. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
31. Mogensen CE Combined high blood pressure and glucose in type 2 diabetes: Double jeopardy BMJ 317 1998 693 694
32. Hollander PA Elbein SC Hirsch IB Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study Diabetes Care 21 1998 1288 1294
33. Saleh YM Mudaliar SR Henry RR Metabolic and vascular effects of the thiazolidinedione troglitazone Diabetes Rev 7 1999 55 76
34. Ballard DJ Humphrey LL Melton LJ Epidemiol-ogy of persistent proteinuria in type II diabetes mellitus Diabetes 37 1988 405 412
35. Raine AE Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetic patients in Europe Diabetologia 36 1993 1099 1104
36. Ohno T Kato N Shimizu M Effect of age on the development or progression of albuminuria in non-insulin-dependent diabetes mellitus (NIDDM) without hypertension Diabetes Res 22 1993 115 121
37. Burden AC McNally PG Feehally J Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom Diabet Med 9 1992 641 645
38. Perneger TV Brancati FL Whelton PK End-stage renal disease attributable to diabetes mellitus Ann Intern Med 121 1994 912 918
39. Nelson RG Bennett PH Beck GJ Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Re-nal Disease Study Group N Engl J Med 335 1996 1636 1642
40. Pettitt DJ Saad MF Bennett PH Familial predis-position to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus Diabetologia 33 1990 438 443
41. Freedman BI Tuttle AB Spray BJ Familial predisposi-tion to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus Am J Kidney Dis 25 1995 710 713
42. Ordonez JD Hiatt R Comparison of type II and type I diabetics treated for end-stage renal disease in a large prepaid health plan population Nephron 51 1989 524 529
43. Barker DJP Osmond C Winter PD Weight in infancy and death from ischaemic heart disease Lancet 2 1989 577 580
44. Hales CN Barker DJP Clark PMS Fetal and infant growth and impaired glucose tolerance at age 64 BMJ 303 1991 1019 1022
45. Schmidt S Schone N Ritz E Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group Kidney Int 47 1995 1176 1181
46. Parving HH Tarnow L Rossing P Genetics of diabetic nephropathy J Am Soc Nephrol 7 1996 2509 2517
47. Yoshida H Kon V Ichikawa I Polymorphisms of the renin-angiotensin system genes in progressive renal diseases Kidney Int 50 1996 732 744
48. Doi Y Yoshizumi H Yoshinari M Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM Diabetologia 39 1996 97 102
49. Schmidt S Strojek K Grzeszczak W Excess of DD homozygotes in haemodialysed patients with type II diabetes. The Diabetic Nephropathy Study Group Nephrol Dial Transplant 12 1997 427 429
50. Ruiz J Blanche H Cohen N Insertion/ deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabete Proc Natl Acad Sci U S A 91 1994 3662 3665
51. Herzog CA Ma JZ Collins AJ Poor long-term sur-vival after acute myocardial infarction among patients on long-term dialysis N Engl J Med 339 1998 799 805
52. Schmidt S Giebel R Bergis KH Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy Nephrol Dial Transplant 1 1996 1755 1761
53. Trevisan R Fioretto P Barbosa J Insulin-dependent diabetic sibling pairs are concordant for sodium-hydrogen antiport activity Kidney Int 55 1999 2383 2389
54. Siffert W Rosskopf D Moritz A Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension J Clin Invest 96 1995 759 766
55. Keane WF Nemoto T The role of lipids in the progression of renal disease Current Practice of Medicine 2 1999 14 16
56. Werle E Fiehn W Hasslacher C Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients Diabetes Care 21 1998 994 998
57. Nelson RG Pettitt DJ Baird HR Pre-diabetic blood pressure predicts urinary albumin excretion after the onset of type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians Diabetologia 36 1993 998 1001
58. Viberti GC Earle K Predisposition to essential hypertension and the development of diabetic nephropathy J Am Soc Nephrol 3 1992 S27 S33
59. Ritz E Hasslacher C Mann JF Hypertension and vascular disease as complications in diabetes Laragh JH Brenner BM Hypertension-Pathophysiology, Diagnosis and Management 1990 Raven Press Stamford, CT 1705
60. Biesenbach G Janko O Zazgornik J Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus Nephrol Dial Transplant 9 1994 1097 1102
61. Gall MA Nielsen FS Smidt UM The course of kidney function in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy Diabetologia 36 1993 1071 1078
62. Hansson L Zanchetti A Carruthers SG Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) Lancet 351 1998 1755 1762
63. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes BMJ 317 1998 703 713
64. Nelson RG Knowler WC Pettitt DJ Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM Diabetes Care 18 1995 182 187
65. Lee ET Lee VS Lu M Incidence of renal failure in NIDDM. The Oklahoma Indian Diabetes Study Diabetes 43 1994 572 579
66. Savage S Nagel NJ Estacio RO Clinical factors associated with urinary albumin excretion in type II diabetes Am J Kidney Dis 25 1995 836 844
67. The effect of intensive treatment of diabetes on the development and progression of long-term complica-tions in insulin-dependent diabetes mellitus. The Dia-b N Engl J Med 329 1993 977 986
68. Niskanen L Laakso M Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus Metabolism 42 1993 1541 1545
69. Mykkanen L Haffner SM Kuusisto J Microalbu-minuria precedes the development of NIDDM Diabetes 43 1994 552 557
70. Gambara V Mecca G Remuzzi G Heteroge-neous nature of renal lesions in Type II diabetes J Am Soc Nephrol 8 1993 1458 1466
71. Efficacy of atenolol and captopril in reducing risk of macrovascu-lar and microvascular complications in type 2 diabetes: UKPDS 39 BMJ 317 1998 713 720
72. Hoogeveen EK Kostense PJ Jager A Serum homocysteine level and protein intake are related to risk of microalbuminuria: The Hoorn Study Kidney Int 54 1998 203 209
73. Sasaki T Kurata H Nomura K Amelioration of proteinuria with pravastatin in hypercholesterolemic patients with diabetes mellitus Jpn J Med 29 1990 156 163
74. Tuttle KR Puhlman ME Cooney SK Urinary albumin and insulin as predictors of coronary artery disease: an angiographic study Am J Kidney Dis 34 1999 918 925
75. The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) Can J Cardiol 12 1996 127 137
76. Imano E Kanda T Nakatani Y Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy Diabetes Care 21 1998 2135 2139
77. Ravid M Savin H Jutrin I Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients Ann Intern Med 118 1993 577 581
78. Lebovitz HE Wiegmann TB Cnaan A Renal protective effects of enalapril in hypertensive NIDDM:Role of baseline albuminuria Kidney Int 45 1994 S
79. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study G BMJ 302 1991 210 216
80. Nosadini R Brocco E Saller A Renal function in noninsulin-dependent diabetes mellitus patients treated with angiotensin-converting enzyme inhibitors and calcium channel blockers J Hypertension 16 1998 S27 S32
81. Maschio G Alberti D Janin G Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency N Engl J Med 334 1996 939 945
82. Ruggenenti P Mosconi L Bianchi L Long-term treatment with either enalapril or nitrendipine stabi-lizes albuminuria and increases glomerular filtrationrate in non-insulin-dependent diabetic pa Am J Kidney Dis 24 1994 753 761
83. Bakris GL Copley JB Vicknair N Calcium channel blockers versus other antihypertensive thera-pies on progression of NIDDM associated nephropa-thy Kidney Int 50 1996 1641 1650
84. Bakris GL Weir MR DeQuattro V Effects of an ACE inhibitor/ calcium antagonist combination on proteinuria in diabetic nephropathy Kidney Int 54 1998 1273 1289
85. 85.U.S. Renal Data System: USRDS 1999 Annual Data Report. National Institutes of Health, National Insti-tute of Diabetes and Digestive and Kidney Diseases. Be
86. Collins A Umen A Kjellstrand CM Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality Am J Kidney Dis 15 1990 422 432